TEX12
gene geneOn this page
Summary
TEX12 (testis expressed 12, HGNC:11734) is a protein-coding gene on chromosome 11q23.1, encoding Testis-expressed protein 12 (Q9BXU0). Component of the transverse central element of synaptonemal complexes (SCS), formed between homologous chromosomes during meiotic prophase.
This gene is similar to a mouse gene that is expressed in the testis.
Source: NCBI Gene 56158 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 19 total
- MANE Select transcript:
NM_031275
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:11734 |
| Approved symbol | TEX12 |
| Name | testis expressed 12 |
| Location | 11q23.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000150783 |
| Ensembl biotype | protein_coding |
| OMIM | 605791 |
| Entrez | 56158 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000280358, ENST00000530752, ENST00000863453
RefSeq mRNA: 1 — MANE Select: NM_031275
NM_031275
CCDS: CCDS31679
Canonical transcript exons
ENST00000280358 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001409147 | 112167372 | 112167487 |
| ENSE00001506867 | 112171772 | 112172556 |
| ENSE00003508978 | 112169253 | 112169331 |
| ENSE00003641208 | 112170419 | 112170530 |
| ENSE00003651395 | 112170623 | 112170674 |
Expression profiles
Bgee: expression breadth ubiquitous, 150 present calls, max score 91.42.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0313 / max 31.1249, expressed in 4 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 116711 | 0.0158 | 4 |
| 116710 | 0.0155 | 3 |
Top tissues by expression
279 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 91.42 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.59 | gold quality |
| right testis | UBERON:0004534 | 82.19 | gold quality |
| left testis | UBERON:0004533 | 81.47 | gold quality |
| testis | UBERON:0000473 | 79.99 | gold quality |
| buccal mucosa cell | CL:0002336 | 76.54 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 61.11 | gold quality |
| monocyte | CL:0000576 | 60.44 | gold quality |
| mononuclear cell | CL:0000842 | 60.34 | gold quality |
| gastrocnemius | UBERON:0001388 | 60.23 | gold quality |
| adult organism | UBERON:0007023 | 60.13 | gold quality |
| muscle of leg | UBERON:0001383 | 59.97 | gold quality |
| right coronary artery | UBERON:0001625 | 58.99 | gold quality |
| leukocyte | CL:0000738 | 58.38 | gold quality |
| muscle organ | UBERON:0001630 | 57.07 | gold quality |
| popliteal artery | UBERON:0002250 | 55.76 | gold quality |
| tibial artery | UBERON:0007610 | 55.74 | gold quality |
| skin of leg | UBERON:0001511 | 54.76 | gold quality |
| skin of abdomen | UBERON:0001416 | 54.59 | gold quality |
| calcaneal tendon | UBERON:0003701 | 54.55 | gold quality |
| aorta | UBERON:0000947 | 54.19 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 53.91 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 53.36 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 53.34 | gold quality |
| ectocervix | UBERON:0012249 | 53.12 | gold quality |
| mucosa of stomach | UBERON:0001199 | 53.11 | gold quality |
| zone of skin | UBERON:0000014 | 52.92 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 52.69 | gold quality |
| thoracic aorta | UBERON:0001515 | 52.28 | gold quality |
| ascending aorta | UBERON:0001496 | 52.27 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.78 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): E2F6
miRNA regulators (miRDB)
40 targeting TEX12, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
| HSA-MIR-374A-5P | 99.90 | 71.34 | 2923 |
| HSA-MIR-374B-5P | 99.90 | 69.98 | 2734 |
| HSA-MIR-8067 | 99.86 | 69.59 | 2260 |
| HSA-MIR-7856-5P | 99.75 | 69.99 | 2901 |
| HSA-MIR-2681-5P | 99.75 | 67.64 | 1655 |
| HSA-MIR-875-3P | 99.63 | 69.47 | 2548 |
| HSA-MIR-208B-5P | 99.42 | 70.83 | 1952 |
| HSA-MIR-330-3P | 99.41 | 69.95 | 2521 |
| HSA-MIR-513A-3P | 99.39 | 70.63 | 3620 |
| HSA-MIR-513C-3P | 99.39 | 70.63 | 3620 |
| HSA-MIR-3606-5P | 99.31 | 69.67 | 1168 |
| HSA-MIR-329-5P | 99.27 | 68.11 | 1597 |
| HSA-MIR-4477B | 99.23 | 70.49 | 1733 |
| HSA-MIR-4528 | 99.18 | 69.77 | 1936 |
Literature-anchored findings (GeneRIF, showing 5)
- a model of chromosome synapsis driven by growth of SYCE2-TEX12 higher-order structures within the CE of the SC. (PMID:22870393)
- This result suggests that regular expression of TEX11, TEX12, TEX14 and TEX15 is essential for the early stages of spermatogenesis. (PMID:29932616)
- Structural basis of meiotic chromosome synaptic elongation through hierarchical fibrous assembly of SYCE2-TEX12. (PMID:34373646)
- Centrosome dysfunction associated with somatic expression of the synaptonemal complex protein TEX12. (PMID:34880391)
- A Novel Frameshift Microdeletion of the TEX12 Gene Caused Infertility in Two Brothers with Nonobstructive Azoospermia. (PMID:37012491)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tex12 | ENSMUSG00000032065 |
| rattus_norvegicus | Tex12 | ENSRNOG00000049470 |
Protein
Protein identifiers
Testis-expressed protein 12 — Q9BXU0 (reviewed: Q9BXU0)
All UniProt accessions (1): Q9BXU0
UniProt curated annotations — full annotation on UniProt →
Function. Component of the transverse central element of synaptonemal complexes (SCS), formed between homologous chromosomes during meiotic prophase. Requires SYCP1 in order to be incorporated into the central element.
Subunit / interactions. Interacts with SYCE2.
Subcellular location. Chromosome.
Tissue specificity. Testis specific.
RefSeq proteins (1): NP_112565* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029193 | TEX12 | Family |
Pfam: PF15219
UniProt features (5 total): compositionally biased region 2, chain 1, region of interest 1, helix 1
Structure
Experimental structures (PDB)
5 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 6HK9 | X-RAY DIFFRACTION | 1.45 |
| 6HK8 | X-RAY DIFFRACTION | 2.11 |
| 6R2F | X-RAY DIFFRACTION | 2.29 |
| 6R17 | X-RAY DIFFRACTION | 2.42 |
| 6YQF | X-RAY DIFFRACTION | 3.33 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BXU0-F1 | 80.40 | 0.58 |
Function
Pathways and Gene Ontology
Reactome pathways
4 pathways
| ID | Pathway |
|---|---|
| R-HSA-1221632 | Meiotic synapsis |
| R-HSA-1474165 | Reproduction |
| R-HSA-1500620 | Meiosis |
| R-HSA-1640170 | Cell Cycle |
MSigDB gene sets: 90 (showing top):
GOBP_MEIOTIC_CHROMOSOME_SEGREGATION, GOBP_CHROMOSOME_ORGANIZATION, REACTOME_MEIOTIC_SYNAPSIS, GOBP_SYNAPTONEMAL_COMPLEX_ORGANIZATION, GOBP_ORGANELLE_FISSION, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4, GOBP_DNA_DAMAGE_RESPONSE, GOBP_CHROMOSOME_ORGANIZATION_INVOLVED_IN_MEIOTIC_CELL_CYCLE, GOBP_DNA_BIOSYNTHETIC_PROCESS, GOBP_DNA_SYNTHESIS_INVOLVED_IN_DNA_REPAIR, GOBP_HOMOLOGOUS_CHROMOSOME_SEGREGATION, GOBP_MEIOTIC_CELL_CYCLE_PROCESS, LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP, WEBER_METHYLATED_ICP_IN_SPERM_DN, GOBP_HOMOLOGOUS_CHROMOSOME_PAIRING_AT_MEIOSIS
GO Biological Process (3): meiotic DNA repair synthesis (GO:0000711), synaptonemal complex assembly (GO:0007130), meiotic cell cycle (GO:0051321)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (3): central element (GO:0000801), chromosome (GO:0005694), synaptonemal complex (GO:0000795)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Meiosis | 1 |
| Reproduction | 1 |
| Cell Cycle | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA synthesis involved in DNA repair | 1 |
| meiosis I cell cycle process | 1 |
| homologous chromosome pairing at meiosis | 1 |
| cellular component assembly | 1 |
| chromosome organization involved in meiotic cell cycle | 1 |
| synaptonemal complex organization | 1 |
| cell cycle | 1 |
| sexual reproduction | 1 |
| reproductive process | 1 |
| meiotic nuclear division | 1 |
| binding | 1 |
| synaptonemal complex | 1 |
| cellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
| synaptonemal structure | 1 |
Protein interactions and networks
STRING
486 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TEX12 | SYCE2 | Q6PIF2 | 997 |
| TEX12 | SYCE1 | Q8N0S2 | 987 |
| TEX12 | SYCE3 | A1L190 | 969 |
| TEX12 | SYCP1 | Q15431 | 968 |
| TEX12 | SYCP3 | Q8IZU3 | 922 |
| TEX12 | C14orf39 | Q8N1H7 | 866 |
| TEX12 | SYCP2 | Q9BX26 | 809 |
| TEX12 | HORMAD1 | Q86X24 | 749 |
| TEX12 | HORMAD2 | Q8N7B1 | 598 |
| TEX12 | SPO11 | Q9Y5K1 | 594 |
| TEX12 | RAD21L1 | Q9H4I0 | 593 |
| TEX12 | REC8 | O95072 | 586 |
| TEX12 | STAG3 | Q9UJ98 | 583 |
| TEX12 | SMC1B | Q8NDV3 | 575 |
| TEX12 | TEX15 | Q9BXT5 | 558 |
IntAct
93 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SGF29 | TEX12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF835 | TEX12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NUP54 | TEX12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| INCA1 | TEX12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM161B | TEX12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TEX12 | FAM9C | psi-mi:“MI:0915”(physical association) | 0.560 |
| TEX12 | LENG1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TEX12 | ZNF835 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM9C | TEX12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LENG1 | TEX12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| AP2B1 | TEX12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| AIMP2 | TEX12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PPP1R13B | TEX12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SYCE2 | TEX12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCNC | TEX12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| OIP5 | TEX12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MESD | TEX12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMARCE1 | TEX12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| COX5B | TEX12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SUOX | TEX12 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (20): TEX12 (Two-hybrid), TEX12 (Two-hybrid), TEX12 (Two-hybrid), TEX12 (Two-hybrid), TEX12 (Two-hybrid), TEX12 (Two-hybrid), TEX12 (Two-hybrid), TEX12 (Two-hybrid), TEX12 (Two-hybrid), TEX12 (Two-hybrid), TEX12 (Two-hybrid), TEX12 (Two-hybrid), MSGN1 (Two-hybrid), FAM161B (Two-hybrid), SYCE2 (Two-hybrid)
ESM2 similar proteins: A0A1P8ARG1, A0A1S3X835, A6NKT7, B3LHE1, E7KNG0, E7NHN2, E7Q3U9, F4HVS6, F4HYG2, F4I131, F4IJK1, F4KEW8, O48767, O95816, P0DMS1, P21651, P46640, P48002, Q10006, Q12912, Q1T763, Q2T9U9, Q3UYG1, Q3ZBG5, Q56WM6, Q5XVI1, Q811D2, Q8LPQ1, Q8S8C6, Q91YN9, Q93ZY2, Q94CG5, Q94FL6, Q9BXU0, Q9C8Y4, Q9C9F5, Q9CR81, Q9FG14, Q9FX84, Q9LEZ4
Diamond homologs: Q9BXU0, Q9CR81
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| TEX12 | “form complex” | Synaptonemal_complex | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
19 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 12 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
979 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:112167412:G:GT | donor_gain | 1.0000 |
| 11:112170408:T:TA | acceptor_gain | 1.0000 |
| 11:112170417:A:AG | acceptor_gain | 1.0000 |
| 11:112170418:G:GA | acceptor_gain | 1.0000 |
| 11:112170418:G:GG | acceptor_gain | 1.0000 |
| 11:112170418:GT:G | acceptor_gain | 1.0000 |
| 11:112171770:A:AG | acceptor_gain | 1.0000 |
| 11:112171771:G:GG | acceptor_gain | 1.0000 |
| 11:112171936:C:G | donor_gain | 1.0000 |
| 11:112167415:G:GG | donor_gain | 0.9900 |
| 11:112167483:G:GT | donor_gain | 0.9900 |
| 11:112167484:A:T | donor_gain | 0.9900 |
| 11:112167495:G:GT | donor_gain | 0.9900 |
| 11:112170405:T:G | acceptor_gain | 0.9900 |
| 11:112170413:T:A | acceptor_gain | 0.9900 |
| 11:112170414:GTTA:G | acceptor_loss | 0.9900 |
| 11:112170418:GTC:G | acceptor_gain | 0.9900 |
| 11:112170418:GTCT:G | acceptor_gain | 0.9900 |
| 11:112170418:GTCTC:G | acceptor_gain | 0.9900 |
| 11:112170533:G:GT | donor_gain | 0.9900 |
| 11:112171771:GT:G | acceptor_gain | 0.9900 |
| 11:112171771:GTGA:G | acceptor_gain | 0.9900 |
| 11:112171889:A:AG | donor_gain | 0.9900 |
| 11:112171890:G:GG | donor_gain | 0.9900 |
| 11:112171893:A:AG | donor_gain | 0.9900 |
| 11:112171894:T:G | donor_gain | 0.9900 |
| 11:112171913:A:G | donor_gain | 0.9900 |
| 11:112167395:G:GT | donor_gain | 0.9800 |
| 11:112167396:A:T | donor_gain | 0.9800 |
| 11:112167483:G:T | donor_gain | 0.9800 |
AlphaMissense
812 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:112171861:A:T | K106I | 0.991 |
| 11:112171830:G:C | A96P | 0.989 |
| 11:112171873:T:C | L110P | 0.977 |
| 11:112171852:T:C | L103P | 0.972 |
| 11:112171862:A:C | K106N | 0.963 |
| 11:112171862:A:T | K106N | 0.963 |
| 11:112171876:G:C | R111P | 0.963 |
| 11:112171779:G:C | A79P | 0.959 |
| 11:112171861:A:C | K106T | 0.955 |
| 11:112170661:G:C | A72P | 0.952 |
| 11:112171791:G:C | A83P | 0.952 |
| 11:112171819:T:C | L92P | 0.952 |
| 11:112171865:A:C | R107S | 0.948 |
| 11:112171865:A:T | R107S | 0.948 |
| 11:112171894:T:A | I117N | 0.947 |
| 11:112171831:C:A | A96D | 0.941 |
| 11:112171885:T:C | F114S | 0.941 |
| 11:112171873:T:G | L110R | 0.940 |
| 11:112171896:G:C | A118P | 0.934 |
| 11:112171873:T:A | L110Q | 0.932 |
| 11:112171906:T:C | L121S | 0.932 |
| 11:112171782:G:C | A80P | 0.923 |
| 11:112170671:T:C | L75S | 0.917 |
| 11:112171894:T:G | I117S | 0.907 |
| 11:112169316:G:C | R16S | 0.905 |
| 11:112169316:G:T | R16S | 0.905 |
| 11:112171789:A:T | D82V | 0.904 |
| 11:112171843:A:T | E100V | 0.897 |
| 11:112170668:T:C | L74P | 0.894 |
| 11:112171852:T:A | L103Q | 0.891 |
dbSNP variants (sampled 300 via entrez): RS1000638355 (11:112172350 AT>A,ATT), RS1000974740 (11:112172244 T>C), RS1000987659 (11:112172046 T>C), RS1001115507 (11:112165457 C>T), RS1001346612 (11:112166485 T>A), RS1001698495 (11:112166143 T>A), RS1002805417 (11:112171586 T>G), RS1002831237 (11:112171456 G>A,T), RS1003235889 (11:112169766 C>T), RS1003473356 (11:112170306 G>A), RS1003929188 (11:112171187 C>T), RS1004023983 (11:112170934 A>G), RS1004595689 (11:112166324 A>G), RS1005035655 (11:112165973 A>C), RS1005746839 (11:112171421 T>C)
Disease associations
OMIM: gene MIM:605791 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002255_1 | Inflammatory biomarkers | 2.000000e-32 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004812 | interleukin-1 beta measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB variants
3 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs187238 | IL18, TEX12 | 3 | 2.50 | 1 | interferons;ribavirin |
| rs1946518 | IL18, TEX12 | 3 | 3.25 | 2 | tacrolimus;interferons;ribavirin |
| rs5744247 | IL18, TEX12 | 3 | 2.25 | 1 | tacrolimus |
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| fluorene-9-bisphenol | decreases expression | 1 |
| sodium arsenate | decreases expression, increases abundance | 1 |
| Arsenic | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Folic Acid | decreases expression | 1 |
| Lead | affects methylation | 1 |
| Methotrexate | decreases expression | 1 |
| Progesterone | affects response to substance | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Lactic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.